Aim of study is to evaluate the results of retrograde stenting of biliary tract upon pathology of pancreatobiliary area.
In 2008-2012, 65 patients (28 men and 37 women) with abnormal pancreatobiliary area aged from 33 to 86 underwent 85 manipulations of retrograde stenting of the bile duct. Obstructive jaundice was present in 44 (67.7%) of 65 patients, the content of total bilirubin ranged from 58 to 570 mmol/L. In 14 (21%) cases the clinical picture of suppurative cholangitis was registered.
Before stenting, we performed ultrasound examination of the abdomen, esophagogastroduodenoscopy, endoscopic ultrasonography, endoscopic retrograde cholangiography, computed tomography of the abdomen, electrocardiography, chest X-ray, blood tests and urine tests, liver function tests, consultation of cardiologist. To perform endoscopic ultrasonography of pancreatobiliary area we used videoehogastroscope GF-UM160 «Olympus».
On the basis of endoscopic ultrasonography and retrograde cholangiography, groups of patients were formed, depending on the cause and the level of the block of the biliary tract (Table 1) . While stenting the biliary tract, endoscopic video system -Olympus V-70‖ with a therapeutic duodenoscope TJF-V70 with a diameter of 4.2 mm of instrument channel, as well as X-ray digital apparatus stenoscope 6000 CCD (-General Electric‖) and plastic biliary stents with a diameter from 2.5 to 3.3 mm were used. (Fig. 1, 2) .
Efficacy of retrograde endoprosthetics of bile ducts was achieved in all 14
patients: clinical picture of jaundice disappeared, as well as cholangitis and pain syndrome, normalization of biochemical parameters was achieved.
Complications after 67 endoprosthetics of bile ducts in patients with benign pathology of pancreatobiliary area were recorded in 4 (5.9%) cases, when we diagnosed stent migrations to the choledoch with the development of the clinical picture of jaundice, and in 1 case a patient with the migration of the stent in choledoch had suppurative cholangitis (Table 2 ). In the group of patients with malignant pathology of pancreatobiliary area complications developed in 1 (11.1%) patients in the form of suppurative cholangitis due to stent obstruction by mucous plug, which was eliminated after the installation of nasobiliary drainage with subsequent readjustment of the common bile duct. The nature and severity of complications after stenting of the bile ducts in groups of patients with malignant and benign disease of pancreatobiliary area varied, but were not life-threatening and in all cases were eliminated at the endoscopic stage.
In foreign and home literature stenting of the bile ducts is most frequently mentioned in the context of palliative treatment of biliary obstruction due to malignant pathology. In our work we have expanded the indications for endoprosthetics of the bile ducts due to patients with intradiverticular location of the big duodenal papilla, Mirizzi syndrome, sclerosing cholangitis and in patients with postmanipulative pancreatitis who underwent stenting of the main pancreatic duct (Fig. 3, 4 ).
Wirsung duct stenting was performed in the next 2 days after papillosphincterotomy that allowed stopping pain for 2-3 days and avoiding the development of pancreatic necrosis. Our experience in the pancreatic duct stenting is small (6 patients). Typically, the intervention included a one-time execution of pancreatic and biliduodenal prosthetics. Pancreatic stents were removed within 5-6 days after their installation.
In patients with a high risk of acute postmanipulative pancreatitis, when stricture of the terminal part of the common bile duct and papillostenosis combined, papillosphincterotomy completed choledochal endoprosthetics. It was possible to reduce the incidence of transient amylasemia and clinical picture of acute pancreatitis in those patients from 18 to 3%.
Conclusion.
Endoscopic retrograde biliary stenting is a safe and effective treatment option for patients with both benign and malignant pancreatobiliary diseases, it is characterized by low rate of specific complications (5.8%) and had reduced the risk of acute pancreatitis in patients with papillostenosis and stricture of the common bile duct terminal part down to 3%. 
